Eton Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Eton Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $71. The average 1-year stock price forecast is 15.48% higher than the current stock price, while the lowest is $68 (+10.61%) and the highest is $76 (+23.62%).

Price Target: $71 (+15.48%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$68	$71	$70	$76
Change	+10.61%	+15.48%	+13.86%	+23.62%

Analyst Ratings

The average analyst rating for Eton Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	3	3	3	3	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Reiterates $65 → $70	Buy	Reiterates	$65 → $70	+13.86%	Aug 14, 2026
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Buy Reiterates $62 → $76	Buy	Reiterates	$62 → $76	+23.62%	Aug 13, 2026
Gary Nachman Canaccord Genuity	Canaccord Genuity	Buy Reiterates $60	Buy	Reiterates	$60	-2.41%	Jul 30, 2026
Madison Elsaadi B. Riley Securities	B. Riley Securities	Buy Reiterates $40	Buy	Reiterates	$40	-34.94%	Jun 26, 2026

Financial Forecast

Revenue This Year

149.70M

from 79.95M

87.24%

from 79.95M

Revenue Next Year

219.91M

from 149.70M

46.90%

from 149.70M

EPS This Year

1.40

from 0.32

337.50%

from 0.32

EPS Next Year

2.58

from 1.40

84.29%

from 1.40

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	21.83M	21.25M	31.64M	39.01M	79.95M	149.70M
Revenue Growth	55,879.49%	-2.66%	48.90%	23.29%	104.94%	87.24%
Gross Profit	19.01M	14.32M	21.06M	23.41M	47.83M	99.70M
Gross Margin	87.05%	67.38%	66.56%	60.01%	59.83%	66.60%
Operating Income	-1.50M	-8.26M	-1.19M	-2.18M	4.83M	40.87M
Net Income	-1.96M	-9.02M	-936.00K	-3.82M	-4.60M	35.44M
EPS	-	-	-	-	0.32	1.40
EPS Growth	-	-	-	-	-	337.50%
Forward PE	9.98	32.85	79.64	57.91	30.56	43.91
Free Cash Flow	-7.02M	5.36M	5.60M	-18.78M	11.16M	38.32M
No. Analysts	-	-	-	-	-	4

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	152.3M
Avg	149.7M
Low	147.6M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	90.5%
Avg	87.2%
Low	84.6%

EPS Forecast

Chart

EPS	2026	2027	2028
High	1.52
Avg	1.40
Low	1.28

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	375.0%
Avg	337.5%
Low	300.0%